Avalere 2021 Healthcare Industry Outlook: Clearing the Path

Summary

The accelerated changes and increased uncertainties in healthcare brought on by the COVID-19 pandemic will continue into 2021, and its impacts are likely to shape healthcare for years to come. While prevalent uncertainty is a given, the broad outline of a new era is already emerging. More than ever, careful examination of healthcare stakeholder’s business models, policy developments, and data will be essential to arrive at accurate assessments of the future state. Our experts engaged in a live discussion covering critical issues facing healthcare leaders and strategies for clearing the path.

For even deeper coverage, download the 2021 Healthcare Industry Outlook document below.

Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.

Access the Outlook Webinar and Report

Sarah Butler led 4 panel discussions exploring the key healthcare questions for the upcoming year and evidence-based strategies for life sciences companies, health plans, and providers to overcome potential access barriers and improve health outcomes.

Key Topics

Navigating the post-election policy landscape, including the COVID-19 pandemic, health disparities, drug pricing, and access to healthcare coverage
Addressing patient affordability, drug pricing, the role of Center for Medicare & Medicaid Innovation
Using data and innovative care models to address healthcare disparities, public health issues, and the consequences of delayed and deferred care
Understanding the emerging COVID-19 vaccines and therapeutics marketplace and the role of the Food & Drug Administration

Panelists

Speaker

Elizabeth Carpenter , President

As president of Avalere Health, Elizabeth Carpenter is responsible for the firm’s consulting, sales, and operational functions.

Speaker

Kelly L. George , Principal, Market Access & Reimbursement

Kelly L. George, PhD, RAC, supports clients in navigating the FDA policy environment for the development and lifecycle of drugs and biologics.

Speaker

Lance Grady , Executive Vice President, Life Sciences Strategy & Growth

Lance Grady is the head of Avalere’s Life Sciences Strategy & Growth.

Speaker

Matt Kazan , Managing Director, Policy

Matt Kazan advises health plans, life sciences clients, and patient organizations as they navigate the policy landscape, focusing on Medicare Part D and Medicare Advantage, and implementation of the Inflation Reduction Act.

Speaker

John C. Neal , Managing Director, Commercialization & Regulatory Strategy

John Neal partners with pharmaceutical and biotechnology clients to develop market access assessments and launch strategies to ensure successful asset commercialization.

Guest Speaker

Sarah Butler , Head, Client Solutions, Marketing & Operations, Avalere Health

Sarah Butler specializes in evidence-based medicine, value-based contracting, and strategy development.

Guest Speaker

Nick Diamond , Consultant II, Avalere Health

Nicholas J Diamond, JD, LLM, MBe, provides strategic counsel on health policy and market access issues spanning US (federal, state, and local) and international markets.

Guest Speaker

John E. Linnehan , Practice Director, Health Economics & Advanced Analytics, Avalere Health

John E Linnehan leads a team of consultants, strategists, and data scientists focused on driving healthcare improvement through value demonstration, stakeholder engagement, predictive and applied analytics, and data innovations.

Guest Speaker

Kristi Mitchell , Practice Director, Avalere Health

Kristi Mitchell specializes in the use of clinical data for strategic decision-making across multiple industries, including life sciences, health plans, and professional societies.

Guest Speaker

Chris Sloan , Principal, Policy, Avalere Health

Chris Sloan advises a number of clients, including pharmaceutical manufacturers, health plans, providers, and patient groups on key policy issues facing the healthcare industry.